Picture courtesy India TV
New Delhi: The Pune-based Serum Institute of India (SII) has said the COVID-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly with strict adherence to all protocols.
The SII comment on Thursday came after AstraZeneca and Oxford University acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine candidate, news agency PTI reported.
A statement describing the error came days after the company and the university described the shots as “highly effective” and made no mention of why some study participants did not receive as much vaccine in the first of two shots as expected.
The SII said, “The AstraZeneca-Oxford vaccine is safe and effective. Even the lowest efficacy results are at 60-70%, making it a viable vaccine against the virus.”
Claiming that varied age groups with different dosage forms will result in slight variations and efficacy, SII added, “We must be patient and not panic”.
SII is conducting clinical trials of AstraZeneca-Oxford’s COVID-19 vaccine candidate in India.
New Delhi: The central government has sent a notice to Wikipedia—which endorses itself as a…
Bhubaneswar: Four journalists from Odisha sustained critical injuries when as the SUV carrying them rammed…
Puri: Gajapati Maharaja Dibyasingha Deb on Tuesday said legal action would be initiated against International…
New Delhi: In a big relief to about 16,000-odd madrasas in Uttar Pradesh, the Supreme…
Bhubaneswar: A young man was critically injured after being attacked by three bike-borne miscreants in…
Off with his head', orders the Queen of Hearts and off goes a head. The…
Ottawa: A Canadian cop, identified as Sergeant Harinder Sohi—a Peel Regional Police officer— was reportedly…
Koraput: In a shocking incident, A woman was allegedly killed after the assailants tied her…